A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection
This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection. An electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both s...
Saved in:
Published in | Surgery Vol. 157; no. 4; pp. 690 - 698 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.04.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0039-6060 1532-7361 1532-7361 |
DOI | 10.1016/j.surg.2014.12.009 |
Cover
Abstract | This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection.
An electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both subject headings (MeSH) and truncated word searches to identify all articles published that related to this topic. Pooled risk ratios were calculated for categorical outcomes and mean differences for secondary continuous outcomes using the fixed-effects and random-effects models for meta-analysis.
Seven studies involving 218 patients met the inclusion criteria. There was no difference in the increase in FLR between the 2 groups 39% (PVE) versus 27% (PVL; mean difference [MD] 6.04; 95% CI, −0.23, 12.32; Z = 1.89; P = .06). Similarly, there was no difference in the morbidity (risk ratio [RR], 1.08; 95% CI, 0.55, 2.09; Z = 0.21; P = .83) and mortality (RR, 0.87; 95% CI, 0.19, 3.92; Z = 0.18; P = .85) in the 2 groups after liver resection. While awaiting liver resection after PVL and PVE, no difference was noted in the number of patients developing disease progression (RR, 0.93; 95% CI, 0.52, 1.66; Z = 0.24; P = .81). In a subset analysis comparing FLR with PVE and PVL as part of the procedure called an associating liver partition with PVL for staged hepatectomy (ALPPS), there was a significant increase in FLR in favor of ALPPS (MD, −17.09; 95% CI, −32.78, −1.40; Z = 2.14; P = .03).
PVL and PVE result in comparable percentage increase in FLR with similar morbidity and mortality rates. The ALPPS procedure results in an improved percentage increase in FLR compared with PVE alone. |
---|---|
AbstractList | This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection.
An electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both subject headings (MeSH) and truncated word searches to identify all articles published that related to this topic. Pooled risk ratios were calculated for categorical outcomes and mean differences for secondary continuous outcomes using the fixed-effects and random-effects models for meta-analysis.
Seven studies involving 218 patients met the inclusion criteria. There was no difference in the increase in FLR between the 2 groups 39% (PVE) versus 27% (PVL; mean difference [MD] 6.04; 95% CI, -0.23, 12.32; Z = 1.89; P = .06). Similarly, there was no difference in the morbidity (risk ratio [RR], 1.08; 95% CI, 0.55, 2.09; Z = 0.21; P = .83) and mortality (RR, 0.87; 95% CI, 0.19, 3.92; Z = 0.18; P = .85) in the 2 groups after liver resection. While awaiting liver resection after PVL and PVE, no difference was noted in the number of patients developing disease progression (RR, 0.93; 95% CI, 0.52, 1.66; Z = 0.24; P = .81). In a subset analysis comparing FLR with PVE and PVL as part of the procedure called an associating liver partition with PVL for staged hepatectomy (ALPPS), there was a significant increase in FLR in favor of ALPPS (MD, -17.09; 95% CI, -32.78, -1.40; Z = 2.14; P = .03).
PVL and PVE result in comparable percentage increase in FLR with similar morbidity and mortality rates. The ALPPS procedure results in an improved percentage increase in FLR compared with PVE alone. This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection.INTRODUCTIONThis meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection.An electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both subject headings (MeSH) and truncated word searches to identify all articles published that related to this topic. Pooled risk ratios were calculated for categorical outcomes and mean differences for secondary continuous outcomes using the fixed-effects and random-effects models for meta-analysis.METHODSAn electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both subject headings (MeSH) and truncated word searches to identify all articles published that related to this topic. Pooled risk ratios were calculated for categorical outcomes and mean differences for secondary continuous outcomes using the fixed-effects and random-effects models for meta-analysis.Seven studies involving 218 patients met the inclusion criteria. There was no difference in the increase in FLR between the 2 groups 39% (PVE) versus 27% (PVL; mean difference [MD] 6.04; 95% CI, -0.23, 12.32; Z = 1.89; P = .06). Similarly, there was no difference in the morbidity (risk ratio [RR], 1.08; 95% CI, 0.55, 2.09; Z = 0.21; P = .83) and mortality (RR, 0.87; 95% CI, 0.19, 3.92; Z = 0.18; P = .85) in the 2 groups after liver resection. While awaiting liver resection after PVL and PVE, no difference was noted in the number of patients developing disease progression (RR, 0.93; 95% CI, 0.52, 1.66; Z = 0.24; P = .81). In a subset analysis comparing FLR with PVE and PVL as part of the procedure called an associating liver partition with PVL for staged hepatectomy (ALPPS), there was a significant increase in FLR in favor of ALPPS (MD, -17.09; 95% CI, -32.78, -1.40; Z = 2.14; P = .03).RESULTSSeven studies involving 218 patients met the inclusion criteria. There was no difference in the increase in FLR between the 2 groups 39% (PVE) versus 27% (PVL; mean difference [MD] 6.04; 95% CI, -0.23, 12.32; Z = 1.89; P = .06). Similarly, there was no difference in the morbidity (risk ratio [RR], 1.08; 95% CI, 0.55, 2.09; Z = 0.21; P = .83) and mortality (RR, 0.87; 95% CI, 0.19, 3.92; Z = 0.18; P = .85) in the 2 groups after liver resection. While awaiting liver resection after PVL and PVE, no difference was noted in the number of patients developing disease progression (RR, 0.93; 95% CI, 0.52, 1.66; Z = 0.24; P = .81). In a subset analysis comparing FLR with PVE and PVL as part of the procedure called an associating liver partition with PVL for staged hepatectomy (ALPPS), there was a significant increase in FLR in favor of ALPPS (MD, -17.09; 95% CI, -32.78, -1.40; Z = 2.14; P = .03).PVL and PVE result in comparable percentage increase in FLR with similar morbidity and mortality rates. The ALPPS procedure results in an improved percentage increase in FLR compared with PVE alone.CONCLUSIONPVL and PVE result in comparable percentage increase in FLR with similar morbidity and mortality rates. The ALPPS procedure results in an improved percentage increase in FLR compared with PVE alone. This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection. An electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both subject headings (MeSH) and truncated word searches to identify all articles published that related to this topic. Pooled risk ratios were calculated for categorical outcomes and mean differences for secondary continuous outcomes using the fixed-effects and random-effects models for meta-analysis. Seven studies involving 218 patients met the inclusion criteria. There was no difference in the increase in FLR between the 2 groups 39% (PVE) versus 27% (PVL; mean difference [MD] 6.04; 95% CI, −0.23, 12.32; Z = 1.89; P = .06). Similarly, there was no difference in the morbidity (risk ratio [RR], 1.08; 95% CI, 0.55, 2.09; Z = 0.21; P = .83) and mortality (RR, 0.87; 95% CI, 0.19, 3.92; Z = 0.18; P = .85) in the 2 groups after liver resection. While awaiting liver resection after PVL and PVE, no difference was noted in the number of patients developing disease progression (RR, 0.93; 95% CI, 0.52, 1.66; Z = 0.24; P = .81). In a subset analysis comparing FLR with PVE and PVL as part of the procedure called an associating liver partition with PVL for staged hepatectomy (ALPPS), there was a significant increase in FLR in favor of ALPPS (MD, −17.09; 95% CI, −32.78, −1.40; Z = 2.14; P = .03). PVL and PVE result in comparable percentage increase in FLR with similar morbidity and mortality rates. The ALPPS procedure results in an improved percentage increase in FLR compared with PVE alone. Introduction This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal vein embolization (PVE) before liver resection. Methods An electronic search was performed of the MEDLINE, EMBASE, and PubMed databases using both subject headings (MeSH) and truncated word searches to identify all articles published that related to this topic. Pooled risk ratios were calculated for categorical outcomes and mean differences for secondary continuous outcomes using the fixed-effects and random-effects models for meta-analysis. Results Seven studies involving 218 patients met the inclusion criteria. There was no difference in the increase in FLR between the 2 groups 39% (PVE) versus 27% (PVL; mean difference [MD] 6.04; 95% CI, −0.23, 12.32; Z = 1.89; P = .06). Similarly, there was no difference in the morbidity (risk ratio [RR], 1.08; 95% CI, 0.55, 2.09; Z = 0.21; P = .83) and mortality (RR, 0.87; 95% CI, 0.19, 3.92; Z = 0.18; P = .85) in the 2 groups after liver resection. While awaiting liver resection after PVL and PVE, no difference was noted in the number of patients developing disease progression (RR, 0.93; 95% CI, 0.52, 1.66; Z = 0.24; P = .81). In a subset analysis comparing FLR with PVE and PVL as part of the procedure called an associating liver partition with PVL for staged hepatectomy (ALPPS), there was a significant increase in FLR in favor of ALPPS (MD, −17.09; 95% CI, −32.78, −1.40; Z = 2.14; P = .03). Conclusion PVL and PVE result in comparable percentage increase in FLR with similar morbidity and mortality rates. The ALPPS procedure results in an improved percentage increase in FLR compared with PVE alone. |
Author | Pandanaboyana, Sanjay Toogood, Giles Bartlett, Adam Lodge, J. Peter Prasad, K. Raj Hidalgo, Ernest Bell, Richard |
Author_xml | – sequence: 1 givenname: Sanjay surname: Pandanaboyana fullname: Pandanaboyana, Sanjay email: sanjay.pandanaboyana@gmail.com organization: St James Hospital, Leeds, West Yorkshire, United Kingdom – sequence: 2 givenname: Richard surname: Bell fullname: Bell, Richard organization: St James Hospital, Leeds, West Yorkshire, United Kingdom – sequence: 3 givenname: Ernest surname: Hidalgo fullname: Hidalgo, Ernest organization: St James Hospital, Leeds, West Yorkshire, United Kingdom – sequence: 4 givenname: Giles surname: Toogood fullname: Toogood, Giles organization: St James Hospital, Leeds, West Yorkshire, United Kingdom – sequence: 5 givenname: K. Raj surname: Prasad fullname: Prasad, K. Raj organization: St James Hospital, Leeds, West Yorkshire, United Kingdom – sequence: 6 givenname: Adam surname: Bartlett fullname: Bartlett, Adam organization: Department of Surgery, Auckland City Hospital, Auckland, New Zealand – sequence: 7 givenname: J. Peter surname: Lodge fullname: Lodge, J. Peter organization: St James Hospital, Leeds, West Yorkshire, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25704417$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk9v1DAQxS1URLeFL8AB5cglYezEToIQUlXxT6rEAZC4WY4zrrw49mIni7afHodtD1SinKzRvN-M_N6ckRMfPBLynEJFgYpX2yot8bpiQJuKsgqgf0Q2lNesbGtBT8gGoO5LAQJOyVlKW8iKhnZPyCnjLTQNbTfk5qJIhzTjpGari4h7i78K5cdiwlmVyit3SDYVwRS7EGflij1aXzh7nfXB5yqmJf3Vw2kIzt4c-ybEAh3q2e4xU1med6S1Dv4peWyUS_js9j0n396_-3r5sbz6_OHT5cVVqTnr5rIVo-EwcM5Q04Hx2gy6G2rTadFzA1oN49iL1oBpOhgp1jVCqzmIsUNsBqjPycvj3F0MPxdMs5xs0uic8hiWJKkQvOk5r1fpi1vpMkw4yl20k4oHeedXFnRHgY4hpYhGajv_-eoclXWSglyjkVu5RiPXaCRlMhufUXYPvZv-IPTmCGE2KGcTZdIWvcbRxuyiHIN9GH97D9fOequV-4EHTNuwxJxwtkCmDMgv68Gs90IbgLYX3_OA1_8e8L_tvwGBvNNv |
CitedBy_id | crossref_primary_10_1155_2015_273641 crossref_primary_10_1016_j_amsu_2018_08_012 crossref_primary_10_1007_s00066_018_1342_y crossref_primary_10_1016_j_jvir_2023_10_029 crossref_primary_10_1016_j_hpb_2016_11_005 crossref_primary_10_3748_wjg_v23_i26_4815 crossref_primary_10_1016_j_clinre_2015_06_024 crossref_primary_10_1097_SLA_0000000000002511 crossref_primary_10_1186_s12876_022_02321_x crossref_primary_10_1016_j_jchirv_2020_11_003 crossref_primary_10_1148_rg_220050 crossref_primary_10_1016_j_hpb_2017_03_003 crossref_primary_10_1111_liv_15287 crossref_primary_10_1186_s12957_024_03538_8 crossref_primary_10_3892_or_2017_5531 crossref_primary_10_1007_s00104_022_01665_0 crossref_primary_10_3390_life13020279 crossref_primary_10_1590_0102_6720202400065e1859 crossref_primary_10_1007_s11912_021_01075_1 crossref_primary_10_1007_s12254_018_0415_z crossref_primary_10_1097_AS9_0000000000000455 crossref_primary_10_1016_j_ejso_2017_05_008 crossref_primary_10_1016_j_jviscsurg_2020_11_014 crossref_primary_10_1136_gutjnl_2023_330029 crossref_primary_10_3348_kjr_2019_0140 crossref_primary_10_1016_j_hbpd_2020_07_005 crossref_primary_10_1016_j_hpb_2024_11_011 crossref_primary_10_1016_j_hpb_2017_07_010 crossref_primary_10_1016_j_heliyon_2024_e27578 crossref_primary_10_1016_j_lfs_2017_09_010 crossref_primary_10_5009_gnl19024 crossref_primary_10_1159_000479850 crossref_primary_10_1016_j_jhep_2016_06_006 crossref_primary_10_1093_bjsopen_zrac131 crossref_primary_10_1186_s42155_022_00312_3 crossref_primary_10_3389_fonc_2022_1021018 crossref_primary_10_1016_j_surge_2021_12_005 crossref_primary_10_1016_j_suronc_2017_05_001 crossref_primary_10_2217_hep_2015_0004 crossref_primary_10_3349_ymj_2021_62_10_918 crossref_primary_10_1016_j_aohep_2020_08_063 crossref_primary_10_1016_j_ijscr_2020_05_043 crossref_primary_10_1016_j_ijsu_2020_01_129 crossref_primary_10_1007_s00104_016_0154_9 crossref_primary_10_1007_s00423_016_1524_y crossref_primary_10_1007_s00423_023_03213_8 crossref_primary_10_11569_wcjd_v29_i3_110 crossref_primary_10_3390_medicina58101422 crossref_primary_10_1111_hpb_12479 crossref_primary_10_3389_fonc_2020_01391 crossref_primary_10_1016_j_surg_2016_12_014 crossref_primary_10_1007_s00053_018_0312_2 crossref_primary_10_4254_wjh_v8_i9_439 crossref_primary_10_1007_s00104_015_0107_8 crossref_primary_10_1016_j_clinre_2020_09_001 crossref_primary_10_1007_s11605_016_3261_5 crossref_primary_10_1016_j_surg_2016_08_039 crossref_primary_10_1007_s00104_018_0661_y crossref_primary_10_1007_s00268_019_05031_w crossref_primary_10_1186_s40792_018_0510_8 crossref_primary_10_1016_j_surg_2017_03_002 crossref_primary_10_3350_cmh_2022_0294 crossref_primary_10_1002_ags3_12414 crossref_primary_10_1002_ags3_12810 crossref_primary_10_1007_s11605_015_2872_6 crossref_primary_10_3348_kjr_2022_0822 crossref_primary_10_1177_0003134820950687 crossref_primary_10_1016_j_jss_2016_10_021 crossref_primary_10_1016_j_hpb_2018_02_636 crossref_primary_10_17998_jlc_2022_11_07 crossref_primary_10_1001_jamasurg_2021_0267 crossref_primary_10_1016_j_hbpd_2021_08_001 crossref_primary_10_16931_1995_5464_2023_3_39_47 crossref_primary_10_1007_s13126_016_0313_y crossref_primary_10_1016_j_ejso_2022_11_010 crossref_primary_10_1016_j_hbpd_2021_12_005 crossref_primary_10_1007_s11605_017_3389_y |
Cites_doi | 10.1159/000184735 10.1097/SLA.0000000000000947 10.1016/S1051-0443(07)61970-8 10.1067/msy.2000.101273 10.1016/j.ejso.2013.08.009 10.1155/2012/454026 10.1080/02841850701424514 10.1007/s11605-007-0410-x 10.3748/wjg.v18.i19.2371 10.1016/j.ejso.2009.12.001 10.1097/SLA.0b013e31824856f5 10.1038/sj.bjc.6604872 10.1097/00000658-200012000-00006 10.1002/bjs.6756 10.1007/s00270-013-0591-5 10.1016/0197-2456(86)90046-2 10.1002/bjs.8955 10.1186/1471-2288-5-13 10.1097/00000658-199808000-00010 10.1245/ASO.2006.03.094 10.1111/j.1477-2574.2012.00607.x 10.1016/j.ijsu.2014.03.009 10.1016/j.jhep.2006.02.020 10.1097/SLA.0b013e31815f6e5b 10.2214/ajr.173.3.10470893 10.1046/j.1365-2168.2000.01535.x 10.1016/j.jamcollsurg.2013.03.004 10.1097/SLA.0b013e3181fc08ca 10.1097/01.SLA.0000048447.16651.7B 10.1016/j.surg.2008.05.015 10.1245/s10434-008-0222-6 10.1111/j.1477-2574.2012.00476.x 10.1016/j.jvir.2012.10.017 10.1016/j.ejso.2012.03.007 10.1001/archsurg.143.10.978 10.1002/sim.1186 10.1097/00000658-200011000-00008 10.1200/JCO.2008.19.9273 10.1001/jama.282.11.1054 10.1245/s10434-012-2864-7 10.1016/S1091-255X(02)00122-1 10.1097/01.sla.0000141198.92114.f6 10.1007/s00270-012-0440-y 10.1002/sim.4780060325 |
ContentType | Journal Article |
Copyright | 2015 Elsevier Inc. Elsevier Inc. Copyright © 2015 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2015 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2015 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.surg.2014.12.009 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1532-7361 |
EndPage | 698 |
ExternalDocumentID | 25704417 10_1016_j_surg_2014_12_009 S003960601400796X 1_s2_0_S003960601400796X |
Genre | Meta-Analysis Comparative Study Systematic Review Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .XZ .~1 0R~ 123 1B1 1CY 1P~ 1~. 1~5 354 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 8F7 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACIEU ACRLP ACRPL ACVFH ACWUS ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FD6 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N4W N9A O-L O9- OAUVE OBH OHH OJ0 OV0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSZ T5K TEORI UDS UGJ UHS UQV UQZ UV1 VVN WH7 X7M YOC Z5R ZGI ZXP ZY1 ~G- AACTN AFKWA AJOXV AMFUW PKN RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c528t-76df50b552ec1b253fbc8b3f8c695f0cabdd967f0f480d1e33e07c506d8ee4b03 |
IEDL.DBID | AIKHN |
ISSN | 0039-6060 1532-7361 |
IngestDate | Thu Sep 04 23:38:43 EDT 2025 Sun Jul 13 01:33:36 EDT 2025 Tue Jul 01 02:47:54 EDT 2025 Thu Apr 24 22:57:54 EDT 2025 Fri Feb 23 02:24:46 EST 2024 Sun Feb 23 10:19:43 EST 2025 Tue Aug 26 16:40:44 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2015 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c528t-76df50b552ec1b253fbc8b3f8c695f0cabdd967f0f480d1e33e07c506d8ee4b03 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
PMID | 25704417 |
PQID | 1665495530 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1665495530 pubmed_primary_25704417 crossref_citationtrail_10_1016_j_surg_2014_12_009 crossref_primary_10_1016_j_surg_2014_12_009 elsevier_sciencedirect_doi_10_1016_j_surg_2014_12_009 elsevier_clinicalkeyesjournals_1_s2_0_S003960601400796X elsevier_clinicalkey_doi_10_1016_j_surg_2014_12_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-04-01 |
PublicationDateYYYYMMDD | 2015-04-01 |
PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Surgery |
PublicationTitleAlternate | Surgery |
PublicationYear | 2015 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Adam, Laurent, Azoulay, Castaing, Bismuth (bib30) 2000; 232 Lam, Laurence, Johnston, Hollands, Pleass, Richardson (bib13) 2013; 15 Demets (bib19) 1987; 6 DerSimonian, Laird (bib18) 1986; 7 Schadde, Ardiles, Robles-Campos, Malago, Machado, Hernandez-Alejandro (bib41) 2014; 260 Yachida, Ikeda, Kaneda, Goda, Maeba, Maeta (bib38) 2000; 87 Simoneau, Aljiffry, Salman, Abualhassan, Cabrera, Valenti (bib11) 2012; 14 Capussotti, Muratore, Baracchi, Lelong, Ferrero, Regge (bib23) 2008; 143 Iida, Aihara, Ikuta, Yoshie, Yamanaka (bib24) 2012; 18 Adam, Wicherts, de Haas, Ciacio, Levi, Paule (bib1) 2009; 27 Hayashi, Baba, Ueno, Nakajo, Kubo, Ueno (bib44) 2007; 48 Adam, Delvart, Pascal, Valeanu, Castaing, Azoulay (bib2) 2004; 240 Kodama, Shimizu, Endo, Miyamoto, Miyasaka (bib34) 2002; 13 Higgins, Green (bib21) Schnitzbauer, Lang, Goessmann (bib40) 2012; 255 van Lienden, Hoekstra, Bennink, van Gulik (bib27) 2013; 36 May, Talenfeld, Madoff (bib4) 2013; 24 Jüni, Witschi, Bloch, Egger (bib22) 1999; 282 Sturesson, Keussen, Tranberg (bib26) 2010; 36 Tschuor, Croome, Sergeant, Cano, Schadde, Ardiles (bib42) 2013; 39 Pamecha, Levene, Grillo, Woodward, Dhillon, Davidson (bib43) 2009; 100 Kishi, Madoff, Abdalla, Palavecino, Ribero, Chun (bib35) 2008; 144 Masi, Cupini, Marcucci, Cerri, Loupakis, Allegrini (bib3) 2006; 13 Shindoh, Vauthey, Zimmitti, Curley, Huang, Mahvash (bib8) 2013; 217 Higgins, Thompson (bib20) 2002; 21 van Gulik, van den Esschert, de Graaf, van Lienden, Busch, Heger (bib10) 2008; 25 de Graaf, van den Esschert, van Lienden, van Gulik (bib9) 2009; 16 Agrawal, Belghiti (bib29) 2011; 253 Heinrich, Jochum, Graf, Clavien (bib39) 2006; 45 Goto, Nagino, Nimura (bib37) 1998; 228 Farges, Belghiti, Kianmanesh (bib36) 2003; 237 van Lienden, van den Esschert, de Graaf, Bipat, Lameris, van Gulik (bib6) 2013; 36 Popescu, Alexandrescu (bib12) 2012; 2012 Broering, Hillert, Krupski, Fischer, Mueller, Achilles (bib14) 2002; 6 Aussilhou, Lesurtel, Sauvanet, Farges, Dokmak, Goasguen (bib15) 2008; 12 Shindoh, Tzeng, Aloia, Curley, Zimmitti, Wei (bib32) 2013; 20 Hozo, Djulbegovic, Hozo (bib17) 2005; 5 Robles, Marín, Lopez-Conesa, Capel, Perez-Flores, Parrilla (bib25) 2012; 38 Wicherts, de Haas, Andreani, Sotirov, Salloum, Castaing (bib45) 2010; 97 Abulkhir, Limongelli, Healey, Damrah, Tait, Jackson (bib7) 2008; 247 Zhang, Zhang, Lau, Chen (bib16) 2014; 12 Nagino, Kamiya, Kanai, Uesaka, Sano, Yamamoto (bib33) 2000; 127 Denys, Abehsera, Sauvanet, Sibert, Belghiti, Menu (bib31) 1999; 173 Knoefel, Gabor, Rehders, Alexander, Krausch, Schulte am Esch (bib28) 2013; 100 Azoulay, Castaing, Krissat, Smail, Hargreaves, Lemoine (bib5) 2000; 232 Higgins (10.1016/j.surg.2014.12.009_bib21) van Gulik (10.1016/j.surg.2014.12.009_bib10) 2008; 25 Aussilhou (10.1016/j.surg.2014.12.009_bib15) 2008; 12 Adam (10.1016/j.surg.2014.12.009_bib30) 2000; 232 Hayashi (10.1016/j.surg.2014.12.009_bib44) 2007; 48 Popescu (10.1016/j.surg.2014.12.009_bib12) 2012; 2012 Adam (10.1016/j.surg.2014.12.009_bib1) 2009; 27 Azoulay (10.1016/j.surg.2014.12.009_bib5) 2000; 232 Hozo (10.1016/j.surg.2014.12.009_bib17) 2005; 5 Denys (10.1016/j.surg.2014.12.009_bib31) 1999; 173 de Graaf (10.1016/j.surg.2014.12.009_bib9) 2009; 16 Robles (10.1016/j.surg.2014.12.009_bib25) 2012; 38 Capussotti (10.1016/j.surg.2014.12.009_bib23) 2008; 143 Shindoh (10.1016/j.surg.2014.12.009_bib32) 2013; 20 Simoneau (10.1016/j.surg.2014.12.009_bib11) 2012; 14 Pamecha (10.1016/j.surg.2014.12.009_bib43) 2009; 100 Schnitzbauer (10.1016/j.surg.2014.12.009_bib40) 2012; 255 Kishi (10.1016/j.surg.2014.12.009_bib35) 2008; 144 Yachida (10.1016/j.surg.2014.12.009_bib38) 2000; 87 Kodama (10.1016/j.surg.2014.12.009_bib34) 2002; 13 Iida (10.1016/j.surg.2014.12.009_bib24) 2012; 18 Zhang (10.1016/j.surg.2014.12.009_bib16) 2014; 12 van Lienden (10.1016/j.surg.2014.12.009_bib6) 2013; 36 Abulkhir (10.1016/j.surg.2014.12.009_bib7) 2008; 247 Broering (10.1016/j.surg.2014.12.009_bib14) 2002; 6 Jüni (10.1016/j.surg.2014.12.009_bib22) 1999; 282 Nagino (10.1016/j.surg.2014.12.009_bib33) 2000; 127 Higgins (10.1016/j.surg.2014.12.009_bib20) 2002; 21 Adam (10.1016/j.surg.2014.12.009_bib2) 2004; 240 van Lienden (10.1016/j.surg.2014.12.009_bib27) 2013; 36 Knoefel (10.1016/j.surg.2014.12.009_bib28) 2013; 100 Agrawal (10.1016/j.surg.2014.12.009_bib29) 2011; 253 Wicherts (10.1016/j.surg.2014.12.009_bib45) 2010; 97 May (10.1016/j.surg.2014.12.009_bib4) 2013; 24 Demets (10.1016/j.surg.2014.12.009_bib19) 1987; 6 Tschuor (10.1016/j.surg.2014.12.009_bib42) 2013; 39 Heinrich (10.1016/j.surg.2014.12.009_bib39) 2006; 45 Shindoh (10.1016/j.surg.2014.12.009_bib8) 2013; 217 Sturesson (10.1016/j.surg.2014.12.009_bib26) 2010; 36 Masi (10.1016/j.surg.2014.12.009_bib3) 2006; 13 Lam (10.1016/j.surg.2014.12.009_bib13) 2013; 15 Farges (10.1016/j.surg.2014.12.009_bib36) 2003; 237 DerSimonian (10.1016/j.surg.2014.12.009_bib18) 1986; 7 Schadde (10.1016/j.surg.2014.12.009_bib41) 2014; 260 Goto (10.1016/j.surg.2014.12.009_bib37) 1998; 228 |
References_xml | – volume: 13 start-page: 1233 year: 2002 end-page: 1237 ident: bib34 article-title: Complications of percutaneous transhepatic portal vein embolization publication-title: J Vasc Interv Radiol – volume: 36 start-page: 25 year: 2013 end-page: 34 ident: bib6 article-title: Portal vein embolization before liver resection: a systematic review publication-title: Cardiovasc Intervent Radiol – volume: 36 start-page: 358 year: 2010 end-page: 364 ident: bib26 article-title: Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - an audit of 26 patients publication-title: Eur J Surg Oncol – volume: 255 start-page: 405 year: 2012 end-page: 414 ident: bib40 article-title: Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings publication-title: Ann Surg – volume: 100 start-page: 617 year: 2009 end-page: 622 ident: bib43 article-title: Effect of portal vein embolisation on the growth rate of colorectal liver metastases publication-title: Br J Cancer – volume: 232 start-page: 777 year: 2000 end-page: 785 ident: bib30 article-title: Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors publication-title: Ann Surg – volume: 97 start-page: 240 year: 2010 end-page: 250 ident: bib45 article-title: Impact of portal vein embolisation on long-term survival of patients with primarily unresectable colorectal liver metastases publication-title: Br J Surg – volume: 16 start-page: 423 year: 2009 end-page: 430 ident: bib9 article-title: Induction of tumor growth after preoperative portal vein embolization: is it a real problem? publication-title: Ann Surg Oncol – volume: 240 start-page: 644 year: 2004 end-page: 658 ident: bib2 article-title: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival publication-title: Ann Surg – volume: 27 start-page: 1829 year: 2009 end-page: 1835 ident: bib1 article-title: Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? publication-title: J Clin Oncol – volume: 5 start-page: 13 year: 2005 ident: bib17 article-title: Estimating the mean and variance from the median, range, and the size of a sample publication-title: BMC Med Res Methodol – volume: 144 start-page: 744 year: 2008 end-page: 751 ident: bib35 article-title: Is embolization of segment 4 portal veins before extended right hepatectomy justified? publication-title: Surgery – volume: 13 start-page: 58 year: 2006 end-page: 65 ident: bib3 article-title: Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer publication-title: Ann Surg Oncol – volume: 12 start-page: 297 year: 2008 end-page: 303 ident: bib15 article-title: Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant publication-title: J Gastrointest Surg – volume: 127 start-page: 155 year: 2000 end-page: 160 ident: bib33 article-title: Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility publication-title: Surgery – volume: 237 start-page: 208 year: 2003 end-page: 217 ident: bib36 article-title: Portal vein embolization before right hepatectomy: prospective clinical trial publication-title: Ann Surg – volume: 232 start-page: 665 year: 2000 end-page: 672 ident: bib5 article-title: Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver publication-title: Ann Surg – volume: 217 start-page: 126 year: 2013 end-page: 133 ident: bib8 article-title: Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach publication-title: J Am Coll Surg – volume: 39 start-page: 1230 year: 2013 end-page: 1235 ident: bib42 article-title: Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion – an extension of the ALPPS approach publication-title: Eur J Surg Oncol – volume: 38 start-page: 586 year: 2012 end-page: 593 ident: bib25 article-title: Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases publication-title: Eur J Surg Oncol – volume: 87 start-page: 1382 year: 2000 end-page: 1390 ident: bib38 article-title: Preventive effect of preoperative portal vein ligation on endotoxin-induced hepatic failure in hepatectomized rats is associated with reduced tumour necrosis factor alpha production publication-title: Br J Surg – volume: 6 start-page: 905 year: 2002 end-page: 913 ident: bib14 article-title: Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant publication-title: J Gastrointest Surg – volume: 247 start-page: 49 year: 2008 end-page: 57 ident: bib7 article-title: Preoperative portal vein embolization for major liver resection: a meta-analysis publication-title: Ann Surg – volume: 282 start-page: 1054 year: 1999 end-page: 1060 ident: bib22 article-title: The hazards of scoring the quality of clinical trials for meta-analysis publication-title: JAMA – volume: 20 start-page: 2493 year: 2013 end-page: 2500 ident: bib32 article-title: Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases publication-title: Ann Surg Oncol – volume: 143 start-page: 978 year: 2008 end-page: 982 ident: bib23 article-title: Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases publication-title: Arch Surg – volume: 2012 start-page: 454026 year: 2012 ident: bib12 article-title: Surgical options for initially unresectable colorectal liver metastases publication-title: HPB Surg – volume: 18 start-page: 2371 year: 2012 end-page: 2376 ident: bib24 article-title: Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation publication-title: World J Gastroenterol – volume: 228 start-page: 209 year: 1998 end-page: 213 ident: bib37 article-title: Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization publication-title: Ann Surg – ident: bib21 article-title: Handbook for systematic reviews of interventions version 5.1.0 [updated 2011 Mar; cited 2014 Aug 14] – volume: 100 start-page: 388 year: 2013 end-page: 394 ident: bib28 article-title: In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection publication-title: Br J Surg – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: bib18 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials – volume: 21 start-page: 1539 year: 2002 end-page: 1558 ident: bib20 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat Med – volume: 260 start-page: 829 year: 2014 end-page: 838 ident: bib41 article-title: Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry publication-title: Ann Surg – volume: 253 start-page: 656 year: 2011 end-page: 665 ident: bib29 article-title: Oncologic resection for malignant tumors of the liver publication-title: Ann Surg – volume: 24 start-page: 241 year: 2013 end-page: 254 ident: bib4 article-title: Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies publication-title: J Vasc Interv Radiol – volume: 6 start-page: 341 year: 1987 end-page: 350 ident: bib19 article-title: Methods for combining randomized clinical trials: strengths and limitations publication-title: Stat Med – volume: 15 start-page: 483 year: 2013 end-page: 491 ident: bib13 article-title: A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases publication-title: HPB (Oxford) – volume: 48 start-page: 721 year: 2007 end-page: 727 ident: bib44 article-title: Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization publication-title: Acta Radiol – volume: 45 start-page: 35 year: 2006 end-page: 42 ident: bib39 article-title: Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice publication-title: J Hepatol – volume: 25 start-page: 436 year: 2008 end-page: 444 ident: bib10 article-title: Controversies in the use of portal vein embolization publication-title: Dig Surg – volume: 173 start-page: 633 year: 1999 end-page: 635 ident: bib31 article-title: Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization publication-title: AJR Am J Roentgenol – volume: 14 start-page: 461 year: 2012 end-page: 468 ident: bib11 article-title: Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases publication-title: HPB (Oxford) – volume: 12 start-page: 437 year: 2014 end-page: 441 ident: bib16 article-title: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery publication-title: Int J Surg – volume: 36 start-page: 1572 year: 2013 end-page: 1579 ident: bib27 article-title: Intrahepatic left to right portoportal venous collateral vascular formation in patients undergoing right portal vein ligation publication-title: Cardiovasc Intervent Radiol – volume: 25 start-page: 436 year: 2008 ident: 10.1016/j.surg.2014.12.009_bib10 article-title: Controversies in the use of portal vein embolization publication-title: Dig Surg doi: 10.1159/000184735 – volume: 260 start-page: 829 year: 2014 ident: 10.1016/j.surg.2014.12.009_bib41 article-title: Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry publication-title: Ann Surg doi: 10.1097/SLA.0000000000000947 – volume: 13 start-page: 1233 year: 2002 ident: 10.1016/j.surg.2014.12.009_bib34 article-title: Complications of percutaneous transhepatic portal vein embolization publication-title: J Vasc Interv Radiol doi: 10.1016/S1051-0443(07)61970-8 – volume: 127 start-page: 155 year: 2000 ident: 10.1016/j.surg.2014.12.009_bib33 article-title: Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility publication-title: Surgery doi: 10.1067/msy.2000.101273 – volume: 39 start-page: 1230 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib42 article-title: Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion – an extension of the ALPPS approach publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2013.08.009 – volume: 2012 start-page: 454026 year: 2012 ident: 10.1016/j.surg.2014.12.009_bib12 article-title: Surgical options for initially unresectable colorectal liver metastases publication-title: HPB Surg doi: 10.1155/2012/454026 – volume: 48 start-page: 721 year: 2007 ident: 10.1016/j.surg.2014.12.009_bib44 article-title: Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization publication-title: Acta Radiol doi: 10.1080/02841850701424514 – volume: 12 start-page: 297 year: 2008 ident: 10.1016/j.surg.2014.12.009_bib15 article-title: Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant publication-title: J Gastrointest Surg doi: 10.1007/s11605-007-0410-x – volume: 18 start-page: 2371 year: 2012 ident: 10.1016/j.surg.2014.12.009_bib24 article-title: Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i19.2371 – volume: 36 start-page: 358 year: 2010 ident: 10.1016/j.surg.2014.12.009_bib26 article-title: Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - an audit of 26 patients publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2009.12.001 – volume: 255 start-page: 405 year: 2012 ident: 10.1016/j.surg.2014.12.009_bib40 article-title: Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings publication-title: Ann Surg doi: 10.1097/SLA.0b013e31824856f5 – volume: 100 start-page: 617 year: 2009 ident: 10.1016/j.surg.2014.12.009_bib43 article-title: Effect of portal vein embolisation on the growth rate of colorectal liver metastases publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604872 – volume: 232 start-page: 777 year: 2000 ident: 10.1016/j.surg.2014.12.009_bib30 article-title: Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors publication-title: Ann Surg doi: 10.1097/00000658-200012000-00006 – volume: 97 start-page: 240 year: 2010 ident: 10.1016/j.surg.2014.12.009_bib45 article-title: Impact of portal vein embolisation on long-term survival of patients with primarily unresectable colorectal liver metastases publication-title: Br J Surg doi: 10.1002/bjs.6756 – volume: 36 start-page: 1572 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib27 article-title: Intrahepatic left to right portoportal venous collateral vascular formation in patients undergoing right portal vein ligation publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-013-0591-5 – volume: 7 start-page: 177 year: 1986 ident: 10.1016/j.surg.2014.12.009_bib18 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 100 start-page: 388 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib28 article-title: In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection publication-title: Br J Surg doi: 10.1002/bjs.8955 – volume: 5 start-page: 13 year: 2005 ident: 10.1016/j.surg.2014.12.009_bib17 article-title: Estimating the mean and variance from the median, range, and the size of a sample publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-5-13 – volume: 228 start-page: 209 year: 1998 ident: 10.1016/j.surg.2014.12.009_bib37 article-title: Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization publication-title: Ann Surg doi: 10.1097/00000658-199808000-00010 – volume: 13 start-page: 58 year: 2006 ident: 10.1016/j.surg.2014.12.009_bib3 article-title: Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer publication-title: Ann Surg Oncol doi: 10.1245/ASO.2006.03.094 – volume: 15 start-page: 483 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib13 article-title: A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases publication-title: HPB (Oxford) doi: 10.1111/j.1477-2574.2012.00607.x – volume: 12 start-page: 437 year: 2014 ident: 10.1016/j.surg.2014.12.009_bib16 article-title: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery publication-title: Int J Surg doi: 10.1016/j.ijsu.2014.03.009 – volume: 45 start-page: 35 year: 2006 ident: 10.1016/j.surg.2014.12.009_bib39 article-title: Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice publication-title: J Hepatol doi: 10.1016/j.jhep.2006.02.020 – volume: 247 start-page: 49 year: 2008 ident: 10.1016/j.surg.2014.12.009_bib7 article-title: Preoperative portal vein embolization for major liver resection: a meta-analysis publication-title: Ann Surg doi: 10.1097/SLA.0b013e31815f6e5b – volume: 173 start-page: 633 year: 1999 ident: 10.1016/j.surg.2014.12.009_bib31 article-title: Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.173.3.10470893 – volume: 87 start-page: 1382 year: 2000 ident: 10.1016/j.surg.2014.12.009_bib38 article-title: Preventive effect of preoperative portal vein ligation on endotoxin-induced hepatic failure in hepatectomized rats is associated with reduced tumour necrosis factor alpha production publication-title: Br J Surg doi: 10.1046/j.1365-2168.2000.01535.x – volume: 217 start-page: 126 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib8 publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2013.03.004 – volume: 253 start-page: 656 year: 2011 ident: 10.1016/j.surg.2014.12.009_bib29 article-title: Oncologic resection for malignant tumors of the liver publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181fc08ca – volume: 237 start-page: 208 year: 2003 ident: 10.1016/j.surg.2014.12.009_bib36 article-title: Portal vein embolization before right hepatectomy: prospective clinical trial publication-title: Ann Surg doi: 10.1097/01.SLA.0000048447.16651.7B – volume: 144 start-page: 744 year: 2008 ident: 10.1016/j.surg.2014.12.009_bib35 article-title: Is embolization of segment 4 portal veins before extended right hepatectomy justified? publication-title: Surgery doi: 10.1016/j.surg.2008.05.015 – volume: 16 start-page: 423 year: 2009 ident: 10.1016/j.surg.2014.12.009_bib9 article-title: Induction of tumor growth after preoperative portal vein embolization: is it a real problem? publication-title: Ann Surg Oncol doi: 10.1245/s10434-008-0222-6 – volume: 14 start-page: 461 year: 2012 ident: 10.1016/j.surg.2014.12.009_bib11 article-title: Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases publication-title: HPB (Oxford) doi: 10.1111/j.1477-2574.2012.00476.x – volume: 24 start-page: 241 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib4 article-title: Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2012.10.017 – volume: 38 start-page: 586 year: 2012 ident: 10.1016/j.surg.2014.12.009_bib25 article-title: Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2012.03.007 – volume: 143 start-page: 978 year: 2008 ident: 10.1016/j.surg.2014.12.009_bib23 article-title: Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases publication-title: Arch Surg doi: 10.1001/archsurg.143.10.978 – volume: 21 start-page: 1539 year: 2002 ident: 10.1016/j.surg.2014.12.009_bib20 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat Med doi: 10.1002/sim.1186 – volume: 232 start-page: 665 year: 2000 ident: 10.1016/j.surg.2014.12.009_bib5 article-title: Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver publication-title: Ann Surg doi: 10.1097/00000658-200011000-00008 – volume: 27 start-page: 1829 year: 2009 ident: 10.1016/j.surg.2014.12.009_bib1 article-title: Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.9273 – volume: 282 start-page: 1054 year: 1999 ident: 10.1016/j.surg.2014.12.009_bib22 article-title: The hazards of scoring the quality of clinical trials for meta-analysis publication-title: JAMA doi: 10.1001/jama.282.11.1054 – volume: 20 start-page: 2493 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib32 article-title: Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2864-7 – volume: 6 start-page: 905 year: 2002 ident: 10.1016/j.surg.2014.12.009_bib14 article-title: Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant publication-title: J Gastrointest Surg doi: 10.1016/S1091-255X(02)00122-1 – ident: 10.1016/j.surg.2014.12.009_bib21 – volume: 240 start-page: 644 year: 2004 ident: 10.1016/j.surg.2014.12.009_bib2 article-title: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival publication-title: Ann Surg doi: 10.1097/01.sla.0000141198.92114.f6 – volume: 36 start-page: 25 year: 2013 ident: 10.1016/j.surg.2014.12.009_bib6 article-title: Portal vein embolization before liver resection: a systematic review publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-012-0440-y – volume: 6 start-page: 341 year: 1987 ident: 10.1016/j.surg.2014.12.009_bib19 article-title: Methods for combining randomized clinical trials: strengths and limitations publication-title: Stat Med doi: 10.1002/sim.4780060325 |
SSID | ssj0009418 |
Score | 2.4354546 |
SecondaryResourceType | review_article |
Snippet | This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation (PVL) and portal... Introduction This meta-analysis aimed to review the percentage increase in future liver remnant (FLR) and perioperative outcomes after portal vein ligation... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 690 |
SubjectTerms | Disease Progression Elective Surgical Procedures - methods Embolization, Therapeutic Hepatectomy - methods Hepatectomy - mortality Humans Hypertrophy Ligation Liver - growth & development Liver - pathology Liver - surgery Liver Neoplasms - surgery Models, Statistical Portal Vein - surgery Postoperative Complications - epidemiology Surgery Treatment Outcome |
Title | A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S003960601400796X https://www.clinicalkey.es/playcontent/1-s2.0-S003960601400796X https://dx.doi.org/10.1016/j.surg.2014.12.009 https://www.ncbi.nlm.nih.gov/pubmed/25704417 https://www.proquest.com/docview/1665495530 |
Volume | 157 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB612wsXBOK1PCojcUOhfsbJcVVRLSD1RKW9WX6iRdukanY5cOC3Y8fOVhWlSByTeORkMp4ZJ983A_BONK0n0fFXTQxnFddGVq2kptImuJoFz2hG-Z7Xywv-eSVWB3A6cWESrLL4_uzTR29dzpwUbZ5crdeJ48tS-p22CFi29eoQjmg8I2ZwtPj0ZXl-U3uXk-yQWVslgcKdyTCvYXf9LSG8-PhVMOES745Pf8s_xzh09ggelgQSLfI9PoYD3z2Bnwt0U5IZZToK0p1Dl36rK10Kj6A-oJxuox9-3aHNWF6j71CCZuyGW9f8pek3haOJYmKLxn450TVGqTgcJdbSSIl4ChdnH7-eLqvSVaGygjbbStYuCGyEoN4SQwULxjaGhcbWrQjYauNcW8uAA2-wI54xj6UVuHaN99xg9gxmXd_5F4BccARbSW3UP-dBGhEcxY43Gpu41dRzIJMulS0lx1Pni42asGXfVdK_SvpXhKqo_zm838tc5YIb945m0ytSE5U0Oj8V48G9UvIuKT-U9TsoooY4Uv1hY3MQe8lbZvrPGd9O9qPi-k0_ZXTn-12cKbV_blPzpjk8z4a1f-7UYTC1iHv5n7O-ggfxSGSg0WuYba93_k3MobbmGA4__CLHZaX8BjI3HV8 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcAFgaCwBYorcatMndiOk2NVUS19nVppb5afaNE2qZpdDhz47XhiZ6uqpUhcY4-cTMYz4-T7ZhD6LOrGF9HxkzqGM8K1kaSRpSHaBFex4FmZUL7n1fSSH8_EbAMdjlwYgFVm3598-uCt85X9rM396_kcOL4M0m84IlDZVLMn6CkXTAKu78vvW5xHw4vkjllDYHpmziSQV7-6-Q74Lj58EwRU4sPR6W_Z5xCFjl6iFzl9xAfpDl-hDd--Rr8O8G1BZpzIKFi3Dl_5pSY6lx3BXcAp2cY__bzFi6G4RtdiAGas-jtj_sp0i8zQxDGtxUO3nOgYo1ScjoGzNBAi3qDLo68Xh1OSeyoQK8p6SWTlgqBGiNLbwpSCBWNrw0Jtq0YEarVxrqlkoIHX1BWeMU-lFbRytffcULaFNtuu9e8QdsEV1MrSRu1zHqQRwZXU8VpTEw-aeoKKUZfK5oLj0PdioUZk2Q8F-legf1WUKup_gvbWMtep3Majs9n4itRIJI2uT8Vo8KiUfEjK93n39qpQfZyp7lnYBIm15B0j_eeKu6P9qLh74ZeMbn23iitB8-cGWjdN0NtkWOvnhv6C0CBu-z9X_YSeTS_OTtXpt_OT9-h5HBEJcvQBbS5vVv5jzKaWZmfYLX8ApW4eKg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+systematic+review+and+meta-analysis+of+portal+vein+ligation+versus+portal+vein+embolization+for+elective+liver+resection&rft.jtitle=Surgery&rft.au=Pandanaboyana%2C+Sanjay%2C+FRCS%2C+MPhil&rft.au=Bell%2C+Richard%2C+MBCHB%2C+MRCS&rft.au=Hidalgo%2C+Ernest%2C+PhD%2C+FRCS&rft.au=Toogood%2C+Giles%2C+MD%2C+FRCS&rft.date=2015-04-01&rft.issn=0039-6060&rft.volume=157&rft.issue=4&rft.spage=690&rft.epage=698&rft_id=info:doi/10.1016%2Fj.surg.2014.12.009&rft.externalDBID=ECK1-s2.0-S003960601400796X&rft.externalDocID=1_s2_0_S003960601400796X |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00396060%2FS0039606014X00048%2Fcov150h.gif |